Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

161
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
161
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

554
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
554
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

205
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
205
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

174
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
174
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

568
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
568
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

580
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI Registry.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Response-guided bulevirtide ± pegylated interferon alfa-2a: Long-term outcomes observed in the nationwide Austrian hepatitis D cohort study.

JHEP reports : innovation in hepatology·2026
Same author

Characterization of ferroportin disease and SLC40A1-related hemochromatosis - Results from the EASL non-HFE registry.

Journal of hepatology·2026
Same author

Ferric carboxymaltose increases fracture risk in patients and reduces bone formation in mice with iron deficiency anemia.

Blood·2026
Same author

Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency.

Hepatology (Baltimore, Md.)·2026
Same author

Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts.

Journal of hepatology·2026

Related Experiment Video

Updated: Dec 20, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.3K

Intravenous iron supplementation therapy.

Benedikt Schaefer1, Eva Meindl1, Sonja Wagner1

  • 1Medical University of Innsbruck, Department of Medicine I, Gastroenterology, Hepatology and Endocrinology, Anichstrasse 35, A-6020, Innsbruck, Austria.

Molecular Aspects of Medicine
|May 24, 2020
PubMed
Summary
This summary is machine-generated.

Modern intravenous iron infusions are safe and effective for iron deficiency anemia when oral iron fails. Emerging complications like hypophosphatemia require careful patient selection and monitoring for optimal outcomes.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.1K
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.4K

Related Experiment Videos

Last Updated: Dec 20, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.3K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.1K
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.4K

Area of Science:

  • Hematology
  • Pharmacology
  • Nanotechnology

Background:

  • Intravenous iron therapy has advanced significantly, evolving from risky treatments to a safe and effective cornerstone for iron deficiency.
  • Modern formulations are nanoparticle-based ferric oxy-hydroxide composites, offering various administration options.
  • Intravenous iron is indicated for patients intolerant or unresponsive to oral iron, or when rapid correction is needed.

Purpose of the Study:

  • To review the evolution, safety, efficacy, and emerging complications of modern intravenous iron formulations.
  • To highlight the importance of appropriate patient selection and monitoring in intravenous iron therapy.

Main Methods:

  • Review of current literature on intravenous iron formulations, including their composition, administration, efficacy, and safety profiles.
  • Analysis of prospective clinical trial data regarding infusion reactions and emerging complications like hypophosphatemia.

Main Results:

  • Modern intravenous iron preparations are generally safe, with comparable moderate to severe infusion reaction rates (<1%) across formulations.
  • Hypophosphatemia (6H syndrome) is a significant emerging complication, affecting 50-74% of patients on ferric carboxymaltose, potentially causing bone issues.
  • Intravenous iron aims to improve quality of life, with hemoglobin levels serving as a surrogate marker.

Conclusions:

  • Intravenous iron therapy is a vital treatment for iron deficiency anemia, offering rapid correction and improved quality of life.
  • Careful selection of iron formulations and vigilant monitoring for adverse events, particularly hypophosphatemia, are crucial for safe and effective treatment.
  • Understanding the risks and benefits of different intravenous iron products is essential for optimizing patient outcomes.